Lakewood-Amedex Biotherapeutics Inc banner

Lakewood-Amedex Biotherapeutics Inc
NASDAQ:LABT

Watchlist Manager
Lakewood-Amedex Biotherapeutics Inc Logo
Lakewood-Amedex Biotherapeutics Inc
NASDAQ:LABT
Watchlist
Price: 2.33 USD -1.27%
Market Cap: $4.1m

Wall St Price Targets

LABT Price Targets Summary
Lakewood-Amedex Biotherapeutics Inc

There are no price targets for LABT.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Lakewood-Amedex Biotherapeutics Inc Competitors:
Price Targets
KRNY
Kearny Financial Corp
12% Upside
NSIT
Insight Enterprises Inc
-36% Downside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Revenue Forecast
is not available for Lakewood-Amedex Biotherapeutics Inc

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Lakewood-Amedex Biotherapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Lakewood-Amedex Biotherapeutics Inc

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Lakewood-Amedex Biotherapeutics Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for Lakewood-Amedex Biotherapeutics Inc
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is LABT's stock price target?
Not Available

LABT does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett